What is your role at Norstella?
As Director, RWD HEOR, I work with clients to design studies that use real-world data to evaluate the clinical effectiveness and economic impact of treatments. I advise on methodological considerations and lead the publication of these findings in peer-reviewed journals or through conference presentations.
Tell us about your real-world data expertise.
I specialize in applying statistical and econometric methods to administrative claims and electronic medical records data, including predictive modeling and machine learning.
What’s been one of the most rewarding or exciting projects that you’ve been a part of and why?
I looked at the early real-world impact of a rare disease treatment that has only been on the market for a couple of years. The sample size was small, so we had to be very thoughtful of how we designed the study, including linking multiple data sources together. We saw both evidence of clinical effectiveness and cost offsets in the early view data, which was exciting!
What does a day in the life of a RWD analyst look like at Norstella?
I spend a lot of time meeting with clients to understand their research objectives, and then writing study protocols to ensure we’ve designed something that is scientifically sound. For projects that are currently in the analysis phase, I review output and think through how to best translate the findings to real world policy makers, who will eventually be looking at the data we produce.
What types of problems are our RWD helping pharma solve?
Generating value and evidence for rare conditions. With how much data we have and the availability to link at the patient level across data assets, we are able to identify patients that are typically hard to find in real-world sources.
When you’re not analyzing data, what do you like to do?
I spend time with my family (I have two young kids) and play music in a few bands (I play bass guitar).